Chronic kidney disease and heart failure: is tolvaptan a safe option to treat refractory hyponatremia?

被引：0
|
作者：
Salterain Gonzalez, N. [1 ]
Esteban Fernandez, A. [1 ]
Lavilla Royo, F. J. [1 ]
Gavira Gomez, J. J. [1 ]
机构：
[1] Univ Navarra, E-31080 Pamplona, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [1] TOLVAPTAN IS SAFE AND EFFICACIOUS IN THE OF HYPONATREMIA IN ACUTE ON CHRONIC LIVER FAILURE
    Arora, Vinod
    Alla, Manasa
    Kumar, Guresh
    Sarin, Shiv Kumar
    [J]. HEPATOLOGY, 2020, 72 : 1116 - 1116
  • [2] Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease
    Yoshioka, K. Kei
    Yoshio, T.
    Matsumura, K.
    Noda, T.
    Ueyama, T.
    Sakuma, T.
    Park, H.
    Iharada, Y.
    Yamamoto, Y.
    Shiojima, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 45 - 45
  • [3] Tolvaptan, hyponatremia, and heart failure
    Zmily, Hammam D.
    Daifallah, Suleiman
    Ghali, Jalal K.
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2011, 4 : 57 - 71
  • [4] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [5] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Mari Katsumata
    Nobuhito Hirawa
    Koichiro Sumida
    Minako Kagimoto
    Yosuke Ehara
    Yuki Okuyama
    Megumi Fujita
    Akira Fujiwara
    Mayumi Kobayashi
    Yusuke Kobayashi
    Yuichiro Yamamoto
    Sanae Saka
    Keisuke Yatsu
    Tetsuya Fujikawa
    Yoshiyuki Toya
    Gen Yasuda
    Kouichi Tamura
    Satoshi Umemura
    [J]. Clinical and Experimental Nephrology, 2017, 21 : 858 - 865
  • [6] EVALUATION OF TOLVAPTAN IN THE TREATMENT OF HYPONATREMIA IN CHRONIC HEART FAILURE PATIENT
    Ping, Yang
    [J]. HEART, 2013, 99 : E221 - E221
  • [7] A Study on the Long-Term Administration of Tolvaptan to Treat Patients with Heart Failure and Chronic Kidney Disease (CKD)
    Mizuhara, Akihiro
    Aoki, Hiromi
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S214 - S214
  • [8] Hyponatremia, Heart Failure, and the Role of Tolvaptan
    O'Connell, John B.
    Alemayehu, Addis
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (02) : 29 - 39
  • [9] Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
    Berl, Tomas
    Quittnat-Pelletier, Friederike
    Verbalis, Joseph G.
    Schrier, Robert W.
    Bichet, Daniel G.
    Ouyang, John
    Czerwiec, Frank S.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04): : 705 - 712
  • [10] TOLVAPTAN FOR THE TREATMENT OF HYPONATREMIA AND CONGESTIVE HEART FAILURE
    Ferrer, E.
    [J]. DRUGS OF TODAY, 2010, 46 (03) : 163 - 171
12345